Stock info Amgen | Filter Basic-Info
Stock: Amgen (US Tech), ISIN: US0311621009
| Last Price | 417.20 | Max Price | 417.20 |
| Min Price | 271.18 | 1 Year return | 64.74 |
| Sector | Health Care | Subsector | Biotechnology |
| Annual report 2020 |
Loading...
Contact info:Street: One Amgen Center DriveZip Code: 913201799City: Thousand OaksCountry: USAPhone: 8054471000Email: investor.relations@amgen.comWebsite: www.amgen.comCEO: Robert A. BradwayCFO: Michael A. Kelly
Sector Review Amgen
Loading...
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 20,840 | 136,070 | 15.32 % |
| 2020 | 20,817 | 153,065 | 13.60 % |
| 2021 | 22,853 | 227,669 | 10.04 % |
| 2022 | 24,596 | 260,393 | 9.45 % |
| 2023 | 25,544 | 215,054 | 11.88 % |
Advice Amgen
News Amgen
Analysts: this year best year ever for Amgen
Tomorrow the American Amgen will report its past quarters results. For this year Amgen 's (located in ) revenue will be around 26.76 billion USD. This is according to the average of the analysts' estimates. The expected revenue would be the highest in her history....
Analysts foresee more revenue Amgen
Next Monday the American Amgen will report its past quarters results. Over the current book year the total revenu from the company based in Thousand Oaks will be 26.18 billion USD (consensus estimates). This is slightly more than 2021's revenue of 25.98 billion...
Analysts expect over 2021 rising revenue Amgen
Amgen will announce it's last quarter's results tomorrow. Over the current book year the total revenue from the company in Thousand Oaks will be 26.05 billion USD (consensus estimates). This is slightly more than 2021's revenue of 25.42 billion USD. Historical...
Amgen completes $1.9B acquisition of Five Prime Therapeutics
Amgen (NASDAQ:AMGN) announces that it has completed its previously announced tender offer to purchase all outstanding shares of Five Prime Therapeutics (NASDAQ:FPRX) in a deal valued at ~$1.9B.
"Five Prime fits squarely within Amgen 's leading oncology...
Amgen to acquire Five Prime Therapeutics for $1.9B
Amgen (NASDAQ:AMGN) and Five Prime Therapeutics (NASDAQ:FPRX) ink merger agreement under which, AMGN will acquire Five Prime for $38.00/share in cash, representing an equity value of ~$1.9B. This acquisition adds Five Prime's innovative pipeline to Amgen 's...
Annual reports Amgen
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile Amgen
No Records Found
Results Amgen
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
Balance Amgen
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
Details Amgen
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
146.21
|
173.90
|
194.67
|
241.07
|
229.92
|
| Eps |
9.74
|
2.24
|
11.01
|
11.49
|
10.08
|
| Price/earnings-ratio |
15.01
|
77.63
|
17.68
|
20.98
|
41.39
|
| Dividend |
3.80
|
3.83
|
4.60
|
5.17
|
5.24
|
| Dividend % |
2.60 %
|
2.20 %
|
2.36 %
|
2.14 %
|
1.26 %
|
| Payout % |
0.39
|
1.71
|
0.42
|
0.45
|
0.52
|
| Book value |
38.50
|
29.13
|
17.31
|
14.59
|
13.32
|
| Market to book |
0.26
|
0.17
|
0.09
|
0.06
|
0.03
|
| Cashflow per stock |
13.34
|
12.90
|
15.64
|
13.80
|
14.86
|
| Stocks |
738
|
722
|
630
|
591
|
578
|
| Market Cap |
107.932.22
|
125.590.58
|
122.564.23
|
142.568.80
|
241.266.76
|
Dividend Amgen
Price info Amgen
|
Date
|
Price
|
|---|---|
|
11 Aug 2026
|
417.20
|
|
07 Aug 2026
|
404.85
|
|
06 Aug 2026
|
407.83
|
|
28 Jul 2026
|
376.26
|
|
14 Jul 2026
|
360.45
|
|
09 Jul 2026
|
363.62
|
|
08 Jul 2026
|
367.99
|
|
07 Jul 2026
|
368.10
|
|
06 Jul 2026
|
366.44
|
|
02 Jul 2026
|
374.15
|
|
01 Jul 2026
|
361.33
|
|
30 Jun 2026
|
362.12
|
|
29 Jun 2026
|
360.55
|
|
26 Jun 2026
|
358.33
|
|
25 Jun 2026
|
352.82
|
|
24 Jun 2026
|
351.43
|
|
23 Jun 2026
|
347.01
|
|
22 Jun 2026
|
344.72
|
|
18 Jun 2026
|
337.60
|
|
17 Jun 2026
|
341.66
|
|
16 Jun 2026
|
347.84
|
|
15 Jun 2026
|
350.53
|
|
12 Jun 2026
|
355.20
|
|
11 Jun 2026
|
354.06
|
|
10 Jun 2026
|
337.73
|
|
09 Jun 2026
|
344.56
|
|
08 Jun 2026
|
345.73
|
|
05 Jun 2026
|
349.58
|
|
04 Jun 2026
|
345.60
|
|
03 Jun 2026
|
338.22
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x |
©2026 ValueSpectrum. All Rights Reserved
Developed and maintained by 